Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Covid-19 entities : Ocugen, inc. save search
Ocugen Announces Positive Top-Line Data for COVID-19 Vaccine Candidate COVAXIN™ (BBV152) in Phase 2/3 Immuno-bridging and Broadening Study: Both Co-primary Endpoints Met
Published: 2023-01-09 (Crawled : 21:00) - biospace.com/
OCGN | News A | $1.315 -0.38% -0.38% 6.5M
|
Health Technology
|
| O: 18.46%
H: 0.65%
C: -18.83%
covid-19 candidate vaccine positive
Ocugen Announces Agreement With Washington University in St. Louis for Commercialization of Intranasal COVID-19 Vaccine in U.S., Europe, and Japan
Published: 2022-09-28 (Crawled : 11:00) - globenewswire.com
OCGN | News A | $1.315 -0.38% -0.38% 6.5M
|
Health Technology
|
| O: 13.74%
H: 0.91%
C: -1.93%
covid-19 japan vaccine commercialization agreement
Ocugen Announces Publication of Positive Results of COVID-19 Vaccine Trial for Children 2-18 in The Lancet Infectious Diseases
Published: 2022-06-21 (Crawled : 12:00) - biospace.com/
OCGN | News A | $1.315 -0.38% -0.38% 6.5M
|
Health Technology
|
| O: 10.89%
H: 0.0%
C: 0.0%
covid-19 children vaccine lancet trial positive publication disease
Ocugen, Inc. Announces U.S. FDA Lifts Clinical Hold on the Submission of Its Investigational New Drug Application for Its COVID-19 Vaccine Candidate COVAXIN™ (BBV152)
Published: 2022-02-18 (Crawled : 23:00) - globenewswire.com
OCGN | News A | $1.315 -0.38% -0.38% 6.5M
|
Health Technology
| Email alert
Add to watchlist
covid-19 clinical hold new drug fda bbv152 application xin drug covid vaccine submission
Ocugen/Harris Poll Finds Americans Want More COVID-19 Vaccine Options
Published: 2022-02-15 (Crawled : 12:30) - globenewswire.com
OCGN | News A | $1.315 -0.38% -0.38% 6.5M
|
Health Technology
|
| O: 3.16%
H: 3.86%
C: 3.86%
covid-19 america covid vaccine
Ocugen Partner, Bharat Biotech, Announces Positive Immunogenicity and Safety Data From COVAXIN™ (BBV152), COVID-19 Candidate Vaccine, in Children 2 – 18 YEARS
Published: 2021-12-30 (Crawled : 15:30) - globenewswire.com
OCGN | News A | $1.315 -0.38% -0.38% 6.5M
|
Health Technology
|
| O: -4.79%
H: 21.34%
C: 15.83%
bbv152 covid-19 xin covid positive children biotech vaccine iot
New Data Suggest COVAXIN™ (BBV152) Vaccine Candidate Generates Robust Immune Memory to COVID-19 and Variants of Concern for At Least Six Months After Vaccination
Published: 2021-12-15 (Crawled : 12:30) - globenewswire.com
OCGN | News A | $1.315 -0.38% -0.38% 6.5M
|
Health Technology
|
| O: 5.61%
H: 9.84%
C: 6.69%
bbv152 covid-19 xin covid vaccine
COVID-19 News: Ocugen Secures Manufacturing, Ampio Stops Study and More
Published: 2021-06-15 (Crawled : 17:00) - biospace.com/
OCGN | News A | $1.315 -0.38% -0.38% 6.5M
|
Health Technology
|
| O: 15.5%
H: 3.81%
C: -11.58%
COCP | $1.495 -1.39% 7.6K
|
Health Technology
|
| O: -2.92%
H: 2.17%
C: -3.01%
AMPE | $0.242 0.0% 15K
|
Health Technology
|
| O: 6.11%
H: 3.66%
C: -1.05%
covid covid-19
Ocugen Secures Manufacturing Partnership for US Production of COVID-19 Vaccine Candidate, COVAXIN™
Published: 2021-06-15 (Crawled : 12:00) - globenewswire.com
OCGN | News A | $1.315 -0.38% -0.38% 6.5M
|
Health Technology
|
| O: 15.5%
H: 3.81%
C: -11.58%
covid partnership vaccine covid-19
Ocugen to pursue a BLA path in the US for its COVID-19 vaccine candidate
Published: 2021-06-10 (Crawled : 12:00) - biospace.com/
OCGN | News A | $1.315 -0.38% -0.38% 6.5M
|
Health Technology
|
| O: -26.53%
H: 16.96%
C: -2.19%
covid vaccine covid-19
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.